ZA9010337B - Fibroblast growth factor for use in the prevention and treatment of viral infections - Google Patents

Fibroblast growth factor for use in the prevention and treatment of viral infections

Info

Publication number
ZA9010337B
ZA9010337B ZA9010337A ZA9010337A ZA9010337B ZA 9010337 B ZA9010337 B ZA 9010337B ZA 9010337 A ZA9010337 A ZA 9010337A ZA 9010337 A ZA9010337 A ZA 9010337A ZA 9010337 B ZA9010337 B ZA 9010337B
Authority
ZA
South Africa
Prior art keywords
prevention
treatment
growth factor
fibroblast growth
viral infections
Prior art date
Application number
ZA9010337A
Other languages
English (en)
Inventor
Maria Antonietta Verini
Antonietta Verini Maria
Domenico Ungheri
Ungheri Domenico
Carlo Battistini
Battistini Carlo
Paolo Carminati
Carminati Paolo
Guy Mazue
Mazue Guy
Original Assignee
Erba Carlo Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Erba Carlo Spa filed Critical Erba Carlo Spa
Publication of ZA9010337B publication Critical patent/ZA9010337B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A61K38/1825—Fibroblast growth factor [FGF]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
ZA9010337A 1989-12-22 1990-12-21 Fibroblast growth factor for use in the prevention and treatment of viral infections ZA9010337B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT02280489A IT1237795B (it) 1989-12-22 1989-12-22 Fattori di crescita fibroblastici per l'uso nella prevenzione e nel trattamento di infezioni virali.

Publications (1)

Publication Number Publication Date
ZA9010337B true ZA9010337B (en) 1991-10-30

Family

ID=11200616

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA9010337A ZA9010337B (en) 1989-12-22 1990-12-21 Fibroblast growth factor for use in the prevention and treatment of viral infections

Country Status (10)

Country Link
EP (1) EP0460161A1 (it)
JP (1) JPH04504581A (it)
AU (1) AU632890B2 (it)
CA (1) CA2047203A1 (it)
HU (1) HUT62197A (it)
IE (1) IE904593A1 (it)
IL (1) IL96667A0 (it)
IT (1) IT1237795B (it)
WO (1) WO1991009610A1 (it)
ZA (1) ZA9010337B (it)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5714458A (en) * 1990-07-18 1998-02-03 Farmitalia Carlo Erba S.R.L. Stable pharmaceutical compositions containing a fibroblast growth factor
AU2002224113A1 (en) 2000-11-27 2002-06-03 Dnavec Research Inc. Paramyxovirus vector encoding angiogenesis gene and utilization thereof
JP6363833B2 (ja) * 2013-11-22 2018-07-25 ナノシータ株式会社 薄膜状高分子構造体

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE105868T1 (de) * 1985-09-12 1994-06-15 Scios Nova Inc Rekombinanter fibroblast-wachstumsfaktor.
US4929442A (en) * 1986-09-26 1990-05-29 Exovir, Inc. Compositions suitable for human topical application including a growth factor and/or related materials

Also Published As

Publication number Publication date
JPH04504581A (ja) 1992-08-13
IT1237795B (it) 1993-06-17
IT8922804A0 (it) 1989-12-22
AU6970491A (en) 1991-07-24
HUT62197A (en) 1993-04-28
WO1991009610A1 (en) 1991-07-11
EP0460161A1 (en) 1991-12-11
IL96667A0 (en) 1991-09-16
IE904593A1 (en) 1991-07-03
AU632890B2 (en) 1993-01-14
IT8922804A1 (it) 1991-06-22
CA2047203A1 (en) 1991-06-23
HU913022D0 (en) 1992-01-28

Similar Documents

Publication Publication Date Title
ZA896864B (en) Method and composition for the treatment and prevention of viral infections
GB9609932D0 (en) Use of IL-12 and IFN alpha for the treatment of infectious diseases
EP0491861A4 (en) Prophylaxis and therapy of acquired immunodeficiency syndrome
ZA89383B (en) Growth inhibiting agent and the use therof
AU3959193A (en) Heterocyclic compounds and their use in the treatment of type II-diabetes
HUT71768A (en) Interferon regulatory factors 1 and 2 in the diagnosis of tumorogenicity
EP0382551A3 (en) Prevention and treatment of herpes virus infections
EP0437026A3 (en) Use of tandospirone in the treatment of depression
EP0453497A4 (en) Treatment methods and vaccines
AU6748090A (en) Use of caffeine in the treatment of herpes simplex virus infections
ZA9010337B (en) Fibroblast growth factor for use in the prevention and treatment of viral infections
GB9111885D0 (en) Nerve growth factor for use in the prevention and treatment of viral infections
AU4319393A (en) Use of indolocarbazols in aids treatment
GB2255718B (en) Pharmaceutical composition for treating bacterial and / or viral infection
GB9008215D0 (en) Improvements in or relating to the treatment of surfaces
EP0490250A3 (en) Use of interferon and an antimalarial agent for the treatment of malarial infections
AU641157B2 (en) 2-imino-thiadiazoline-5-sulphonamides and their use in the treatment of glaucoma
SG47098A1 (en) Diamines in the treatment of arrhythmia
GB9024895D0 (en) Therapeutic use of fibroblast growth factor
EP0452941A3 (en) Use of isomonools in the treatment and prophylaxis of cancer
GB9010190D0 (en) Composition for the treatment of protozoal disease and their use
IL109356A0 (en) N-substituted-2-azetidinones and their use in the preparation of n-unsubstituted-2-azetidinones
NZ231322A (en) Treatment of viral and/or bacterial infections
NZ233973A (en) Treatment of viral and/or bacterial infections
IL91427A0 (en) Pharmaceutical combination preparations and their use for the prophylaxis or treatment of bacterial infectious diseases